Picture of Acumen Pharmaceuticals logo

ABOS — Acumen Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Acumen Pharmaceuticals, Inc. FY Income From Operations USD -61.138 Million Vs. IBES Estimate USD -58.8 Million

Mar 26 (Reuters) - Acumen Pharmaceuticals, Inc. FY basic EPS USD -1.08.
* FY net income USD -52.371 million vs. IBES estimate USD -49.9 million
* FY operating expenses USD 61.138 million

Recent news on Acumen Pharmaceuticals

See all news